Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Omega 3 in Alcohol Use Disorder
Sponsor: Université Catholique de Louvain
Summary
The goal of this clinical trial is to investigate the biological pathways underlying the beneficial effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) on mental health in patients with alcohol use disorder. The main questions this study aims to answer are: * Can n-3 PUFA improve mood disorders (depression, anxiety), craving for alcohol, cognitive impairments and sociability disorders ? * Are the beneficial effects of n-3 PUFAs due to a modification of the gut microbiota and/or the inflammatory status? Participants will : * take a supplementation of omega-3 or placebo during 3 months * do a brain MRI * be interviewed for a dietary anamnesis * provide blood, stool and saliva samples * perform psychological tests and neuropsychological tasks Researchers will compare active comparator (omega-3) with placebo comparator (olive oil) to see if omega-3 can have a beneficial effect on AUD patients.
Official title: Impact of Omega-3 Polyunsaturated Fatty Acids on Emotional, Cognitive and Biological Alterations in Alcohol Use Disorder
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-06-19
Completion Date
2027-12-31
Last Updated
2023-06-22
Healthy Volunteers
No
Conditions
Interventions
Active Comparator: Omega-3
It is a dietary supplement made of fish oil rich in n-3 PUFA.
Placebo Comparator: olive oil
Refined olive oil is the usual placebo used in studies with n-3 PUFA.
Locations (1)
Cliniques universitaires Saint Luc
Brussels, Belgium